Global Swine Respiratory Diseases Treatment Market, By Causative Agent (Mycoplasma, Bacteria, Virus and Others), Treatment Type (Vaccines and Drugs), Route ofAdministration (Parenteral and Oral), Distribution Channel (Pharmacies, Veterinary Clinics, Veterinary Hospitals and Others) - Industry Trends and Forecast to 2030.
Swine Respiratory Diseases Treatment Market Analysis and Size
Swine respiratory disease is known to be a type of infection caused by pigs. Some of its symptoms include sore throat, fever, body aches and many other infectious agents including Mycoplasma hyopneumoniae and Bordetella bronchiseptica and viruses such as respiratory syndrome (PRRS). Antibiotics, such as tetracycline or enrofloxacin, are commonly used for the treatment of bacterial swine respiratory diseases.
Data Bridge Market Research analyses that the global swine respiratory diseases treatment market which was USD 2,104 million in 2022, is expected to reach USD 3,067 million by 2030, and is expected to undergo a CAGR of 6.3% during the forecast period of 2023 to 2030. “Vaccines” dominates the treatment type segment of global swine respiratory diseases treatment market owing to several benefits, including long-term protection, reduced disease transmission and improved overall health In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Swine Respiratory Diseases Treatment Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015-2020) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Causative Agent (Mycoplasma, Bacteria, Virus and Others), Treatment Type (Vaccines and Drugs), Route of Administration (Parenteral and Oral), Distribution Channel (Pharmacies, Veterinary Clinics, Veterinary Hospitals and Others) |
|
Countries Covered |
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of the Middle East and Africa |
|
Market Players Covered |
Boehringer Ingelheim Vetmedica Inc. (Germany), Norbrook (U.K.), Ceva Santé Animale (France), Zoetis Inc. (U.S.), Agrilabs Inc. (U.S.), Thermo Fisher Scientific Inc (U.S.), Vetoquinol (France), Bimeda holdings PLC (Ireland), Bayer AG (Germany), Elanco Animal Health (U.S.), Virbac Group (France), Merck Animal Health (U.S.), Phibro Animal Health Corporation (U.S.), HESTER BIOSCIENCES LIMITED (India), Neogen Corporation (U.S.), Vaxxinova (Netherlands), IDT Biologika (Germany), Dechra Pharmaceuticals PLC (U.K.), Biogénesis Bagó (Argentina) and Phytobiotics Futterzusatzstoffe GmbH (Germany) |
|
Market Opportunities |
|
Market Definition
The global market for the treatment of swine respiratory diseases refers to the market for drugs, vaccines and other therapeutic products used in the prevention and treatment of swine respiratory diseases. Swine respiratory diseases include a variety of respiratory infections and conditions that affect pigs, including viral, bacterial and parasitic infections
Global Swine Respiratory Diseases Treatment Market Dynamics
Drivers
- Rise in Consumption of Pork and Pork Industry
The increase in global pork consumption due to population growth, changing dietary habits and economic growth is a major driver of the global swine respiratory disease treatment market as it requires maintenance of healthy and productive pig herds to meet the growing demand for pork products.
- Research and Development Proficiencies
Growing research and development expertise in the treatment of veterinary diseases, including swine respiratory diseases, is key to the market. Advances in veterinary medicine and the focus on developing innovative treatment options and therapies are improving efficacy, safety and overall outcomes, increasing the demand for swine respiratory treatment products.
- Rise in Expenditure for Treating Veterinary Disease
Increased investment in animal health infrastructure, diagnosis, treatment and preventive measures reflects a growing recognition of the importance of animal health and welfare. This increased expenditure increases the demand for effective treatments and solutions, which is driving the growth of the global swine respiratory disease treatment market.
Opportunity
- Collaboration with Research Institutions and Veterinary Professionals
Collaboration with research institutes, veterinarians and pig farmers can facilitate the development of new treatment strategies and products. Collaboration with experts in the field can help conduct clinical trials, collect real-world data, and gain insights into the treatment of respiratory diseases in pigs.
Restraint/Challenge
- Limited Treatment Options
Treatment options for swine respiratory diseases may be limited. Innovative or improved therapies targeting specific pathogens or strains may be lacking. This limitation in treatment options can affect the ability to effectively manage and control swine respiratory diseases.
This global swine respiratory diseases treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global swine respiratory diseases treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In March 2022, FDA approved florfenicol injectable solution from Nuflor-S; Merck Animal Health and tulathromycin injection from Arovyn; Merck Animal Health for treating swine respiratory disease. This would help the company to increase its product portfolio
- In September 2021, Invetex and Boehringer Ingelheim announced a collaboration to discover, develop and commercialize innovative veterinary medicines
Global Swine Respiratory Diseases Treatment Market Scope
The global swine respiratory diseases treatment market is segmented on the basis of causative agent, treatment type, route of administration and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Causative Agent
- Mycoplasma
- Bacteria
- Virus
- Others
Treatment Type
- Vaccines
- Drugs
Route of Administration
- Parenteral
- Oral
Distribution Channel
- Pharmacies
- Veterinary Clinics
- Veterinary Hospitals
- Others
Swine Respiratory Diseases Treatment Market Regional Analysis/Insights
The global swine respiratory diseases treatment market is analysed and market size insights and trends are provided by country, causative agent, treatment type, route of administration and distribution channel as referenced above.
The countries covered in the global swine respiratory diseases treatment market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of the Middle East and Africa
North America dominates the global swine respiratory diseases treatment market because of the strong base of healthcare facilities, strong presence of major players in the market and developed infrastructure to treat the disease in this region.
Asia-Pacific is expected to witness significant growth in the global swine respiratory diseases treatment market during the forecast period of 2023 to 2030 due to the increase in government initiatives to treat the veterinary diseases, increasing research and development in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global swine respiratory diseases treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global swine respiratory diseases treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global swine respiratory diseases treatment MARKET. The data is available for historic period 2015-2020.
Competitive Landscape and Global Swine Respiratory Diseases Treatment Market Share Analysis
The global swine respiratory diseases treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global swine respiratory diseases treatment MARKET.
Some of the major players operating in the global swine respiratory diseases treatment market are:
- Boehringer Ingelheim Vetmedica Inc. (Germany)
- Norbrook (U.K.)
- Ceva Santé Animale (France)
- Zoetis Inc. (U.S.)
- Agrilabs Inc. (U.S.)
- Thermo Fisher Scientific Inc (U.S.)
- Vetoquinol (France)
- Bimeda holdings PLC (Ireland
- Bayer AG (Germany)
- Elanco Animal Health (U.S.)
- Virbac Group (France)
- Merck Animal Health (U.S.)
- Phibro Animal Health Corporation (U.S.)
- HESTER BIOSCIENCES LIMITED (India)
- Neogen Corporation (U.S.)
- Vaxxinova (Netherlands)
- IDT Biologika (Germany)
- Dechra Pharmaceuticals PLC (U.K.)
- Biogénesis Bagó (Argentina)
- Phytobiotics Futterzusatzstoffe GmbH (Germany)
SKU-
